Insider · CIK 0001866258
Hing C Wong
Files at HCWB (HCW Biologics Inc.). First filing May 9, 2025, latest Jul 31, 2026.
In brief
Hing C Wong files SEC Form 4 as CEO, director and 10% owner at HCWB (HCW Biologics Inc.). Since May 9, 2025, Hing C Wong has reported 4 open-market buys worth $2.7M and 0 open-market sells worth $0, the latest filed on Jul 31, 2026.
A track record needs three past buys with six months of prices behind them; Hing C Wong has 2, so none is measured yet.
The newest scored trade: bought $60k of HCWB on Jul 29, 2026, filed Jul 31, 2026, scored 66 (notable). In the last 12 months: 2 buys worth $220k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
HCWB: HCW Biologics Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 66Notable | HCW Biologics Inc. | $60k 23,210 shares | +23% | +60% from low-93% from high | |
| 65Notable | HCW Biologics Inc. | $160k 113,879 shares | +23% | +978% from low-65% from high | |
| 52Moderate | HCW Biologics Inc. | $60k 8,054 shares | +2% | - | |
| 71Notable | HCW Biologics Inc. | $2.4M 92,500 shares | +23% | - |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 29, 2026 | HCWB HCW Biologics Inc. | POpen-market purchase Common Stock | +23,210 | $2.59 | $60k | 125,845 | Jul 31, 2026 |
| May 22, 2026 | HCWB HCW Biologics Inc. | POpen-market purchase Common Stock | +113,879 | $1.41 | $160k | 615,790 | May 27, 2026 |
| May 22, 2026 | HCWB HCW Biologics Inc. | POpen-market purchase Common Stock Purchase Warrantderivative | +113,879 | $0.00 | $0 | 118,110 | May 27, 2026 |
| May 16, 2025 | HCWB HCW Biologics Inc. | POpen-market purchase Common Stock | +8,054 | $7.45 | $60k | 501,911 | May 20, 2025 |
| May 8, 2025 | HCWB HCW Biologics Inc. | POpen-market purchase Common Stock | +92,500 | $26.00 | $2.4M | 493,857 | May 9, 2025 |
| May 7, 2025 | HCWB HCW Biologics Inc. | POpen-market purchase Common Stock Purchase Warrantderivative | +46,250 | $0.00 | $0 | 46,250 | May 9, 2025 |
Questions about Hing C Wong
Answered from the filings on this page, as of the latest one.
Is Hing C Wong buying or selling?
In the last 12 months Hing C Wong reported 2 open-market buys worth $220k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $60k of HCWB on Jul 29, 2026. Grants, option exercises and tax withholding are not counted.
How did Hing C Wong's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Hing C Wong has 2.
Where does Hing C Wong file Form 4?
Hing C Wong has filed Form 4 at HCWB (HCW Biologics Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.